Renaissance Capital logo

MOGU News

US IPO Weekly Recap: Biggest biotech breaks in 3-IPO week

MRNA

Moderna (MRNA) was not the cure for the biotech industry, which has broadly sold off this quarter. Moderna upsized its offering to raise $604 million at a record-shattering $8.1 billion valuation. It is the largest biotech IPO by both deal size and proceeds raised. It also had one of the year's worst first-day returns, tumbling -19%, from $23.00 to $18.60....read more

Chinese fashion portal MOGU prices US IPO at $14, the low end of the range

MOGU

MOGU, a Tencent-backed online fashion marketplace in China, raised $67 million by offering 4.8 million ADSs at $14, the low end of the range of $14 to $16. MOGU plans to list on the NYSE under the symbol MOGU. Morgan Stanley, Credit Suisse and China Renaissance acted as lead managers on the deal....read more

US IPO Week Ahead: Largest-ever biotech IPO Moderna leads 4-deal week

MRNA

Four companies plan to raise $689 million during the week ahead. Biotech giant Moderna (MRNA) continues this year's boom of large biotech IPOs. Developing a platform of messenger RNA, Moderna is raising $500 million at an $8.0 billion valuation. That would make it the largest biotech ever to go public, and the third most highly-valued VC exit in the 2018 IPO...read more

Chinese fashion portal MOGU sets terms for $71 million US IPO

MOGU

MOGU, a Tencent-backed online fashion marketplace in China, announced terms for its IPO on Friday. The company operates the Meilishuo (Meili) and Mogujie fashion platforms. The Hangzhou, China-based company plans to raise $71 million by offering 4.75 million ADSs at a price range of $14 to $16. JD.com has agreed to purchase $30 million worth of ADSs in the offering, or a...read more